- Seed Round,
- Early stage VC,
- Later stage VC,
- Other
Fresh Capital
AN Venture Partners is a Tokyo and San Francisco-based venture capital firm investing in Japanese biotech and life sciences companies that connect Japanese science with the U.S. startup ecosystem. The firm targets multi-stage opportunities, can lead or co-lead investments, and backs therapeutics and enabling-platform companies across biotechnology, neuroscience, pharmaceuticals and healthtech. It invests across Japan and the United States; ANV Fund I closed at $200 million in June 2025.
Email visible after logging in
Example Exampleexample
Marketplaces
